Everyone talks about AI as an efficiency engine. But according to /prompt CEO Paul Dyer, the technology’s greatest impact may be far less visible. In this conversation with Rebecca Willumson, Dyer explains how AI removes friction across workflows, improves knowledge transfer and helps teams focus on the work humans do best. The result is not simply faster execution, but greater confidence throughout the communications process.
Dyer argues that confidence compounds across the pharma communications chain, from internal stakeholders to healthcare professionals and patients. When confidence is high, communications move more quickly and maintain their intended fidelity. He also shares how large language models are influencing patient decision-making by helping users arrive at brand experiences better informed and more confident in their choices.
The conversation also explores AI’s growing role in pharma marketing, including the risk that widespread automation could make content, research and strategy increasingly similar. Dyer discusses why human judgment, creativity and “taste” remain critical differentiators, and what it means for an agency to operate at the frontier of AI-driven transformation.